FDA
approval
· 2013-04-29
FDA Approved: COARTEM — Supplemental Application (Novartis Pharmaceuticals Corporation)
Summary
FDA approved a supplemental application for COARTEM (artemether and lumefantrine) submitted by Novartis Pharmaceuticals Corporation. This constitutes a suppleme…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for COARTEM (ARTEMETHER AND LUMEFANTRINE)